平成25年度採択 文部科学省 私立大学戦略的研究基盤形成支援事業『生体分子情報による次世代型がん個別最適化治療法の開発』(事業番号S1311016)にかかる医学総合研究所第1回国際シンポジウム"Role of Aging and Cancer"を開催いたします。
日時 平成29年8月28日(月) 14:00~19:00
会場 中国体彩网病院 教育研究棟 3階 大教室(アクセス)
プログラム ポスター拡大はこちら>>
Opening Remarks
Prof. Mamoru Suzuki (President of Tokyo Medical University)
Session 1
(1) miRNA in aging and cancer: Prof. Hidetoshi Tahara (Hiroshima University)
(2) Dendritic cell-derived exosomes as Immunotherapy: Dr. Masakatsu Takanashi (Tokyo Medical University)
(3) Cross-talk mediated by bone marrow stromal cell-derived extracellular vesicles: Dr. Tomohiro Umezu (Tokyo Medical University)
(4) Clinical application of mesenchymal stromal cells (Kintaro cellsTM): Mr. Alexei Gladkov (Kintaro Cells Power Corp.)
Session 2
(5) Advances in cancer immunotherapy:Prof. Takayuki Yoshimoto (Tokyo Medical University)
(6) Hypoxia induced paclitaxel resistance via miR-100 as a potential diagnostic biomarker for cervical cancer:Prof. Hirotaka Nishi (Tokyo Medical University)
(7) G-quadruplexes in cancer biology and therapeutics:Dr. Hiroyuki Seimiya (Japanese Foundation for Cancer Research)
(8) Recent advance of telomere biology in neuroblastoma:Prof. Eiso Hiyama (Hiroshima University)
Special Lecture
Recent advances in telomeres and telomerase in relation to aging and cancer: TeSLA, TPE-OLD and 6-thio-2'-deoxyguanosine
Prof. Jerry W. Shay(Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, U.S.A)
Chair: Prof. Kazuma Ohyashiki (Tokyo Medical University)
このニュースに関するお問い合わせ
お問い合わせ:Chikako Kato (Secretariat of the 1st TMU-IMS International Symposium in Tokyo)
E-mail: s-idrc@tokyo-med.ac.jp
TEL&FAX: +81-3-3345-0185
[URL] http://team.tokyo-med.ac.jp/ims_onc/symposium/index.html